Lu Turković

6PUBLICATIONS
12CO-AUTHORS
Molecular targetsInstrumental methods (excl. immunological and bioassay methods)Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 12, 2026
CYP3A4-Mediated Metabolism and Drug-Drug Interaction Potential of Abemaciclib and Letrozole In Vitro.

Martin Kondža, Lu Turković, Hrvoje Rimac

|Nov 17, 2025
Surfactant-enhanced emulsification liquid-liquid microextraction combined with sweeping micellar electrokinetic chromatography-tandem mass spectrometry for therapeutic drug monitoring of alpelisib and fulvestrant in human plasma.

Zvonimir Mlinarić, Lu Turković, Biljana Nigović

|Dec 26, 2023
Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors.

Matea Baković, Martina Bago, Lucija Benić

|Oct 28, 2023
Optimisation of Solid-Phase Extraction and LC-MS/MS Analysis of Six Breast Cancer Drugs in Patient Plasma Samples.

Lu Turković, Dragana Mutavdžić Pavlović, Zvonimir Mlinarić

|Nov 11, 2022
Rapid Capillary Electrophoresis Method for Simultaneous Determination of Abemaciclib, Ribociclib, and Palbociclib in Pharmaceutical Dosage Forms: A Green Approach.

Zvonimir Mlinarić, Lu Turković, Iva Begović

|May 28, 2022
Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment.

Lu Turković, Luka Bočkor, Oscar Ekpenyong

Pageof 1

Frequent Collaborators

5 joint publications

Miranda Sertić

3 joint publications

Biljana Nigović

2 joint publications

Zvonimir Mlinarić

1 joint publications

Luka Bočkor